Statement from Mylan's Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Buy Mylan (MYL) with 'Shoe Dropped' and Options Being Explored - Deutsche Bank
August 8, 2018 11:34 AM EDTDeutsche Bank analyst Gregg Gilbert said clients should buy Mylan (NASDAQ: MYL) with shoe dropped and options being explored.
Gilbert commented, "In a not-so-surprising development, MYLs 2Q results came in light and management lowered its 2018 outlook, primarily based on the re-basing of the US healthcare environment. A key headwind for MYL as it relates to investor... More
Mylan N.V. (MYL) Misses Q2 EPS by 15c, Guidance Misses
August 8, 2018 8:35 AM EDTMylan N.V. (NASDAQ: MYL) reported Q2 EPS of $1.07, $0.15 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $2.96 billion.
GUIDANCE:
Mylan N.V. sees FY2018 EPS of $4.55-$4.90, versus... More



